Card Id
|
Type Of Strain
|
Strain Name
|
Internal Code
|
Gene Symbol
|
Gene Name
|
Disease
|
Stock Type
|
Submitter
|
Developer
|
imsr
|
|
Targeted mutant.
|
129-Ttrtm1
|
Mshum1,M
|
Ttr
|
transthyretin
|
Development Immunology Metabolism Neurobiology
|
|
Unknown Unknown
|
Shuichiro Maeda Dr. EJ R(The First Department of Biochemistry Yamanashi Medical University) Shuichiro Maeda Dr. EJ R(Columbia University)
|
Released publicly
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm1Kwk
|
tmCKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm2Kwk
|
tmNKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm
|
129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm
|
Parp1
|
Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute)
|
|
|
Gene trap.
|
129P2/OlaHsd-Naa25Gt(pGT0pfs)YHA006Byg
|
p120-Naa25Gt(YHA006)Byg
|
Naa25
|
N(alpha)-acetyltransferase 25
|
Neurobiology cancer
|
|
Akira Kakizuka
|
(University of California)
|
|
|
Gene trap.
|
129P2/OlaHsd-Naa25Gt(pGT2lxf)RRK280Byg
|
p120-Naa25Gt(RRK280)Byg
|
Naa25
|
N(alpha)-acetyltransferase 25
|
Neurobiology cancer
|
|
Akira Kakizuka
|
(University of California)
|
|
|
Targeted mutant.
|
Alk2-flox
|
Alk2-flox mouse
|
Acvr1 (synonymous to Alk2)
|
Activin receptor type 1
|
Development Digestive Disorders Hematology Neurobiology Osteosis Urology
|
|
Esumi Shigeyuki
|
Vesa Kaartinen(University of Michigan)
|
|
|
Targeted mutant.
|
B6-Rpt3tm1
|
floxed Rpt3
|
Psmc4
|
proteasome (prosome, macropain) 26S subunit, ATPase, 4
|
Aging Behavior Cell biology Dentistry Dermatology Development Diabetes Digestive Disorders Endocrine Disorders Genetics Hematology Immunology Laboratory-animal Science Metabolism Molecular biology Neurobiology Obesity Ophthalomology Osteosis Otorhinology Reproduction Respiratory System Urology cancer infectious peromelia
|
|
Takahashi Ryosuke
|
Yoshitaka Tashiro , Ryousuke Takahashi(Department of Neurology kyoto University Graduate School of Medicine)
|
|
|
Spontaneous/Chemical induced mutant.
|
B6-Tg(HSP70-Crystallin)Tama
|
H7C
|
Crystallin
|
Crystallin
|
Anatomy Development Neurobiology
|
|
Esumi Shigeyuki
|
Nobuaki Tamamaki
|
|
|
Targeted mutant.
|
B6-Dnm1lem1Card
|
Dnm1l-39
|
Dnm1l
|
dynamin 1-like
|
Hematology Laboratory-animal Science Molecular biology Neurobiology
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Targeted mutant.
|
B6-Dnm1lem2Card
|
Dnm1l-35
|
Dnm1l
|
dynamin 1-like
|
Hematology Laboratory-animal Science Molecular biology Neurobiology
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Transgenic.
|
B6-Tg(Pax7-YFP)
|
Pax7-YFP
|
-
|
Pax7
|
Anatomy Development Metabolism Neurobiology Physiology
|
|
Ono Yusuke
|
(UNITECH)
|
|
|
Targeted mutant.
|
B6.129(ICR)-Parp1tm1Hsmm/Hsmm
|
B6.129(ICR)-Parp1tm1Hsmm/Hsmm
|
Parp1
|
Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmacetical Co. Ltd., National Cancer Center Reasearch Institute)
|
|
|
Targeted mutant.
|
B6.129-Atp1a2tm2Kwk
|
BL6N
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
B6.129-Avpr1btm1
|
B6.129V1b-KO B6.129-Avpr1btm1
|
Avpr1b
|
arginine vasopressin receptor 1B
|
Neurobiology Physiology
|
|
Unknown Unknown
|
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Cckartm1
|
C57BL/6-Cckartm1
|
Cckar
|
Cholecystokinin A receptor
|
Metabolism Neurobiology Physiology cancer
|
|
Okamura Takeshi
|
Soich Takiguchi(National Kyushu Cancer Center)
|
|
|
Targeted mutant.
|
B6.129-Chrm1tm1
|
1NJ B6.129-Chrm1tm1
|
Chrm1
|
cholinergic receptor, muscarinic 1, CNS
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm, Sci., Univ.Tokyo)
|
|
|
Targeted mutant.
|
B6.129-Chrm2tm1
|
2NJ B6.129-Chrm2tm1
|
Chrm2
|
cholinergic receptor, muscarinic 2, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm3tm1
|
3NJ B6.129-Chrm3tm1
|
Chrm3
|
cholinergic receptor, muscarinic 3, cardia
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm4tm1
|
4NJ B6.129-Chrm4tm1
|
Chm4
|
cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch.Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm5tm1
|
5NJ B6.129-Chrm5tm1
|
Chrm5
|
cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(東京大学薬学部)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Edg3tm1Jch
|
SIP3-Knockout
|
Edg3
|
endothelial differentiation, sphingolipid G-protein-coupled receptor,3
|
Development Immunology Metabolism Neurobiology Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Elavl4tm1
|
B6.129-HuDtm1HOkano, HuD KO
|
Elavl 4
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D)
|
Development Neurobiology
|
|
Unknown Unknown
|
Okano Hideyuki(Keio University School of Medicine)
|
|
|
Targeted mutant.
|
B6.129-Kcnj8tm1Kusm
|
Kir6.1 deficient mouse B6.129-Kcnj8tm1Kusm
|
Kcnj8 (Synonym:Kir6.1)
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
Neurobiology Physiology
|
|
Unknown Unknown
|
Susumu Seino(Div Cell & Mol Med, Kobe Univ Grad Sch Med)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Neu3tm1Myg
|
C57BL/6-Neu3tm1Myg
|
Neu3
|
neuraminidase3
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Yamaguchi Kazunori
|
Taeko Miyagi(Miyagi Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Pkmtm1Ntan
|
PkmM1
|
Pkm
|
pyruvate kinase, muscle
|
Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Tanuma Nobuhiro
|
Nobuhiro Tanuma(Miyagi Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Ptger2tm1Sna
|
EP2KO
|
Ptger2
|
prostaglandin E receptor 2 (subtype EP2)
|
Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Narumiya Shuh
|
Shuh Narumiya(Kyoto University Graduate School of Medicine, Department of pharmacology)
|
|
|
Targeted mutant.
|
B6.129-S1pr2tm1Jch
|
SIP2-Knockout
|
S1pr2 (Synonym: Edg5)
|
Endothelial differentiation, sphingolipid G-protein-coupled receptor,5
|
Dermatology Development Immunology Metabolism Neurobiology Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute)
|
|
|
Targeted mutant.
|
B6.129S7-Ttpatm1Csk
|
B6-α-Ttp KO B6.129S7-Ttpatm1Csk
|
Ttpa
|
tocopherol(alpha) transfer protein
|
Development Metabolism Neurobiology Physiology
|
|
Unknown Unknown
|
Jishage Kou-ichi(Chugai Pharmaceutical. co, Ltd.)
|
Released publicly
|
|
Targeted mutant.
|
B6.CB-St8sia1tm1
|
GD3 synthase KO
|
St8sia1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
Neurobiology
|
|
Koichi Furukawa
|
Koichi Furukawa(Masahiko Okada)(Nagasaki University School of Medicine)
|
|
|
Targeted mutant.
|
B6.Cg-Olig2tm1(cre/Esr1)Htak
|
B6-Olig2tm1(cre/Esr1)Htak
|
Olig2
|
Oligodendrocyte transcription factor 2
|
Development Neurobiology
|
|
Takebayashi Hirohide
|
Hirohide Takebayashi(Department of Pathology and Tumor Biology Graduate School of medicine, Kyoto University)
|
|
|
Transgenic.
|
B6.Cg-Tg(CAG-cre)CZ-MO2Osb
|
(CAG-cre)
|
Cre
|
Cre recombinase
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Transgenic.
|
B6.Cg-Tg(CAG-floxed Neo-EGFP)REP08Osb
|
REP-08
|
EGFP
|
green fluorescent protein
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Transgenic.
|
B6.D2-Tg(CAG-floxed Neo-DT)03Osb
|
REP-DT
|
DT
|
Diphtheria toxin gene subunit A
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Gene trap.
|
B6; CB-Fzr1GT(pU-17)Tgen
|
Fzr1/Cdh1(GT)
|
Fzr1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
Aging Development Molecular biology Neurobiology cancer
|
|
Saya Hideyuki
|
(TransGenic, Inc)
|
|
|
Transgenic.
|
B6;(BDF1)-Tg(MCMe1-LacZ)041Ham
|
e1pro
|
LacZ
|
beta-galactosidase
|
Development Neurobiology
|
|
Kato Hideki
|
Yoshifumi Arai(Department of Pathology , Hamamatu University School of Medicine)
|
|
|
Transgenic.
|
B6;(BDF1)-Tg(MCMie-LacZ)064Ham
|
pro1
|
LacZ
|
beta-galactosidase
|
Development Neurobiology
|
|
Kato Hideki
|
Ren-Yong Li(Department of Pathology , Hamamatu University School of Medicine)
|
|
|
Targeted mutant.
|
B6;129(ICR)-Parp1tm1Hsmm Tg(GPT-delta)/Hsmm
|
B6;129(ICR)-Parp1tm1Hsmm TgN(GPT-delta)/Hsmm
|
Parp1 Parp1
|
Poly (ADP-ribose) polymerase family, member 1 Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6;129-Bcl6tm1
|
Bcl6 KO Bcl6 KO (F1)
|
Bcl6
|
B-cell leukemia/lymphoma 6
|
Development Immunology Neurobiology
|
|
Masahiko Hatano
|
Masahiko Hatano(Chiba Univ. School of Medicine)
|
Released publicly
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm2tm1 Chrm4tm1
|
M1M2M4KO
|
Chrm1 Chrm2 Chrm4
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 2 cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1 Chrm5tm1
|
M1M3M5KO
|
Chrm1 Chrm3 Chrm5
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1
|
M1M3KO
|
Chrm1 Chrm3
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm4tm1
|
M2M4KO, C57BL/6J, 2x4
|
Chrm2 Chrm4
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm5tm1
|
2x5
|
Chrm2 Chrm5
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm4tm1
|
3x4
|
Chrm3 Chrm4
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm5tm1
|
3x5
|
Chrm3 Chrm5
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm4tm1 Chrm5tm1
|
M4M5KO, C57BL/6J, 4x5
|
Chrm4 Chrm5
|
cholinergic receptor, muscarinic 4 cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Fez2tm1
|
Fez2 mouse B6;129-Fez2tm1
|
Fez2
|
fasciculation and elongation protein zeta 2 (zygin II)
|
Anatomy Development Neurobiology Physiology
|
|
Unknown Unknown
|
YASUHITO WATANABE(Osaka Bioscience Institute)
|
Released publicly
|
|
Targeted mutant.
|
B6;129-Gpr30tm1
|
GPP30 +/-(CARD ID:#449) B6;129-Gpr30tm1
|
Gpr30
|
G protein-coupled receptor 30
|
Development Neurobiology cancer
|
|
Unknown Unknown
|
Yoichi Mizukami(Center for Gene Research, Yamaguchi University)
|
Released publicly
|
|
Targeted mutant.
|
B6;129-Hpcatm1Toho
|
hippocalcin B6; 129-HPCAtm1toho
|
Hpca
|
hippocalcin
|
Neurobiology Physiology
|
|
Unknown Unknown
|
Tamotsu Masaki(Dept. of Physiology, Toho Univ. Sch. of Med.)
|
Released publicly
|